SCHEMBL4446323

SCHEMBL4446323

Cc1ccc(-c2ccccc2O)cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 2/20 0.50
HSD17B10 Q99714 2/20 0.50
ALDH1A1 P00352 2/20 0.50
BCL2L1 Q07817 1/20 0.50
PDK2 Q15119 1/20 0.48
HPGDS O60760 1/20 0.46
NPC1 O15118 1/20 0.44
PKM P14618 1/20 0.44
RAB9A P51151 1/20 0.44
QPCT Q16769 1/20 0.44
QPCTL Q9NXS2 1/20 0.44
PTGS2 P35354 2/20 0.43
ESR2 Q92731 1/20 0.43
KMT2A Q03164 1/20 0.42
ALOX5AP P20292 1/20 0.41
FEN1 P39748 1/20 0.41
IDO1 P14902 3/20 0.41
TDO2 P48775 1/20 0.41
KDM4E B2RXH2 1/20 0.40
MAPK10 P53779 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5439290 0.79 SMN1; SMN2 (0.65) ALDH1A1PTGS2KMT2AMAPK10SMN1; SMN2
SCHEMBL8289009 0.78 PDK2 (0.47) PDK2HPGDSNPC1PKMRAB9A
SCHEMBL23600754 0.78 ALDH1A1 (0.48) HPGDALDH1A1PDK2HPGDSNPC1
SCHEMBL10264753 0.78 USP7 (0.50) PDK2NPC1PKMRAB9AKMT2A
SCHEMBL8446334 0.78 PTGS2 (0.50) ALDH1A1PDK2NPC1PKMRAB9A
SCHEMBL27814494 0.78 HPGD (0.52) HPGDHSD17B10ALDH1A1BCL2L1NPC1
SCHEMBL27586879 0.76 ALDH1A1 (0.50) HPGDHSD17B10ALDH1A1BCL2L1NPC1
SCHEMBL27761291 0.76 FEN1 (0.55) HPGDHSD17B10ALDH1A1BCL2L1NPC1
Hydrochloric Acid SCHEMBL7235407 0.76 HPGD (0.50) HPGDHSD17B10ALDH1A1BCL2L1NPC1
SCHEMBL9429745 0.76 ENPP3 (0.50) HPGDALDH1A1PDK2NPC1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090156635-A1 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS GILLESPIE PAUL 2009-06-18 US disclosed
US-7524870-B2 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators HOFFMANN-LA ROCHE INC. (US) 2009-04-28 US disclosed
CN-101068803-A Biaryloxymethylarene carboxylic acid compounds HOFFMANN LA ROCHE (CH) 2007-11-07 CN disclosed
US-20060122256-A1 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators GILLESPIE PAUL 2006-06-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156635-A1 BIARYLOXYMETHYLARENECARBOXYLIC ACIDS AS GLYCOGEN SYNTHASE ACTIVATORS GYS2, GYS1, GSK3A HPGD 1332/4885HSD17B10 68/4885ALDH1A1 633/4885
US-20060122256-A1 Biaryloxymethylarenecarboxylic acids as glycogen synthase activators GYS2, GYS1, GSK3A HPGD 1332/4885HSD17B10 68/4885ALDH1A1 633/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.